Hoepner, Robert

Up a level
Export as [feed] RSS
Group by: Date | Item Type | Refereed | No Grouping
Jump to: 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017

2024

Rebsamen, Michael; Capiglioni, Milena; Hoepner, Robert; Salmen, Anke; Wiest, Roland; Radojewski, Piotr; Rummel, Christian (2024). Growing importance of brain morphometry analysis in the clinical routine: The hidden impact of MR sequence parameters. Journal of neuroradiology, 51(1), pp. 5-9. Elsevier Masson 10.1016/j.neurad.2023.04.003

Bagnoud, Maud; Remlinger, Jana; Joly, Sandrine; Massy, Marine; Salmen, Anke; Chan, Andrew; Karathanassis, Dimitris; Evangelopoulos, Maria-Eleptheria; Hoepner, Robert (2024). Predicting glucocorticoid resistance in multiple sclerosis relapse via a whole blood transcriptomic analysis. CNS neuroscience & therapeutics, 30(2), e14484. Wiley 10.1111/cns.14484

Massy, Marine; Hoepner, Robert; Pistor, Maximilian (January 2024). Personalisierte MS-Therapie. Forte. Das Magazin der Schweizerischen Multiple Sklerose Gesellschaft(1), pp. 8-10.

2023

Marti, Stefanie; Hoepner, Andreas G F; Hammer, Helly; Salmen, Anke; Chan, Andrew; Hoepner, Robert (2023). Socioeconomic and Regional Disparities in Industry-Sponsored Clinical Trials in Multiple Sclerosis. JAMA network open, 6(11), e2345619. American Medical Association 10.1001/jamanetworkopen.2023.45619

Lebrun-Frénay, Christine; Siva, Aksel; Sormani, Maria Pia; Landes-Chateau, Cassandre; Mondot, Lydiane; Bovis, Francesca; Vermersch, Patrick; Papeix, Caroline; Thouvenot, Eric; Labauge, Pierre; Durand-Dubief, Françoise; Efendi, Husnu; Le Page, Emmanuelle; Terzi, Murat; Derache, Nathalie; Bourre, Bertrand; Hoepner, Robert; Karabudak, Rana; De Seze, Jérôme; Ciron, Jonathan; ... (2023). Teriflunomide and Time to Clinical Multiple Sclerosis in Patients With Radiologically Isolated Syndrome: The TERIS Randomized Clinical Trial. JAMA neurology, 80(10), pp. 1080-1088. American Medical Association 10.1001/jamaneurol.2023.2815

Remlinger, Jana; Bagnoud, Maud; Meli, Ivo; Massy, Marine; Linington, Christopher; Chan, Andrew; Bennett, Jeffrey L; Hoepner, Robert; Enzmann, Volker; Salmen, Anke (2023). Modelling MOG antibody-associated disorder and neuromyelitis optica spectrum disorder in animal models: Spinal cord manifestations. Multiple Sclerosis and Related Disorders, 78(104892), p. 104892. Elsevier 10.1016/j.msard.2023.104892

Bagnoud, Maud; Remlinger, Jana; Massy, Marine; Lodygin, Dmitri; Salmen, Anke; Chan, Andrew; Lühder, Fred; Hoepner, Robert (2023). In Vivo and In Vitro Evidence for an Interplay between the Glucocorticoid Receptor and the Vitamin D Receptor Signaling. Cells, 12(18) MDPI 10.3390/cells12182291

Remlinger, Jana; Bagnoud, Maud; Meli, Ivo; Massy, Marine; Hoepner, Robert; Linington, Christopher; Chan, Andrew; Bennett, Jeffrey L; Enzmann, Volker; Salmen, Anke (2023). Modeling MOG Antibody-Associated Disorder and Neuromyelitis Optica Spectrum Disorder in Animal Models: Visual System Manifestations. Neurology: Neuroimmunology and Neuroinflammation, 10(5) Wolters Kluwer Health 10.1212/NXI.0000000000200141

Özdemir, Berna C; Espinosa da Silva, Cristina; Arangalage, Dimitri; Monney, Pierre; Guler, Sabina A; Huynh-Do, Uyen; Stirnimann, Guido; Possamai, Lucia; Trepp, Roman; Hoepner, Robert; Salmen, Anke; Gerard, Camille L; Hruz, Petr; Christ, Lisa; Rothschild, Sacha I (2023). Multidisciplinary recommendations for essential baseline functional and laboratory tests to facilitate early diagnosis and management of immune-related adverse events among cancer patients. Cancer immunology, immunotherapy : CII, 72(7), pp. 1991-2001. Springer 10.1007/s00262-023-03436-0

Özdemir, Berna C; Espinosa da Silva, Cristina; Arangalage, Dimitri; Monney, Pierre; Guler, Sabina A; Huynh-Do, Uyen; Stirnimann, Guido; Possamai, Lucia; Trepp, Roman; Hoepner, Robert; Salmen, Anke; Gerard, Camille L; Hruz, Petr; Christ, Lisa; Rothschild, Sacha I (2023). Correction to: Multidisciplinary recommendations for essential baseline functional and laboratory tests to facilitate early diagnosis and management of immune‑related adverse events among cancer patients. Cancer immunology, immunotherapy : CII, 72(7), pp. 2003-2004. Springer 10.1007/s00262-023-03456-w

Léon Betancourt, Alejandro; Schwarzwald, Anina; Millonig, Alban; Oberholzer, Michael; Sabater, Lidia; Hammer, Helly; Kamber, Nicole; Diem, Lara; Chan, Andrew; Hoepner, Robert; Salmen, Anke; Friedli, Christoph (2023). Anti-Kelch-like protein 11 (KLHL11) antibody associated encephalitis -Two case reports and review of the literature. European journal of neurology, 30(6), pp. 1801-1814. Wiley 10.1111/ene.15758

Piredda, Gian Franco; Caneschi, Samuele; Hilbert, Tom; Bonanno, Gabriele; Arun, Joseph; Egger, Karl; Peter, Jessica; Klöppel, Stefan; Jehli, Elisabeth; Grieder, Matthias; Slotboom, Johannes; Seiffge, David; Goeldlin, Martina; Hoepner, Robert; Willems, Tom; Vulliemoz, Serge; Seeck, Margitta; Venkategowda, Punith B.; Corredor Jerez, Ricardo A.; Maréchal, Bénédicte; ... (2023). Submillimeter T 1 atlas for subject‐specific abnormality detection at 7T. Magnetic resonance in medicine, 89(4), pp. 1601-1616. Wiley-Liss 10.1002/mrm.29540

Schwarzwald, A; Salmen, A; Léon Betancourt, A; Diem, L; Hammer, H; Radojewski, P; Rebsamen, M; Kamber, N; Chan, A; Hoepner, R; Friedli, C (2023). Anti-neurochondrin antibody as a biomarker in primary autoimmune cerebellar ataxia - a case report and review of the literature. European journal of neurology, 30(4), pp. 1135-1147. Wiley 10.1111/ene.15648

Rebsamen, Michael; McKinley, Richard; Radojewski, Piotr; Pistor, Maximilian; Friedli, Christoph; Hoepner, Robert; Salmen, Anke; Chan, Andrew; Reyes, Mauricio; Wagner, Franca; Wiest, Roland; Rummel, Christian (2023). Reliable brain morphometry from contrast-enhanced T1w-MRI in patients with multiple sclerosis. Human brain mapping, 44(3), pp. 970-979. Wiley-Blackwell 10.1002/hbm.26117

Rebsamen, Michael; Friedli, Christoph; Radojewski, Piotr; Diem, Lara; Chan, Andrew; Wiest, Roland; Salmen, Anke; Rummel, Christian; Hoepner, Robert (2023). Multiple sclerosis as a model to investigate SARS‐CoV ‐2 effect on brain atrophy. CNS neuroscience & therapeutics, 29(2), pp. 538-543. Wiley 10.1111/cns.14050

Petroulia, Valentina Daphne; Brügger, Dominik; Hoepner, Robert; Vicini, Rino; Winklehner, Anna; Abegg, Mathias; Wagner, Franca (2023). MRI signs helpful in the differentiation of patients with anterior ischaemic optic neuropathy and optic neuritis. The British journal of ophthalmology, 107(1), pp. 121-126. BMJ Publishing Group 10.1136/bjophthalmol-2021-319537

Friedli, Christoph; Wagner, Franca; Hammer, Helly Noemi; Kamber, Nicole; Wiest, Roland; Diem, Lara; Chan, Andrew; Salmen, Anke; Hoepner, Robert (2023). Leptomeningeal enhancement under different MS immunotherapies: A monocentric retrospective cohort study of 214 patients. Multiple sclerosis journal, 29(1), pp. 63-73. Sage 10.1177/13524585221122210

Friedli, Christoph; Salmen, Anke; Hoepner, Robert; Achtnichts, Lutz; Bigi, Sandra; Derfuss, Tobias; Gobbi, Claudio; Kamber, Nicole; Kamm, Christian P; Kuhle, Jens; Lalive, Patrice; Müller, Stefanie; Papadopoulou, Athina; Pot, Caroline; Zecca, Chiara; Chan, Andrew (2023). Specific Aspects of Immunotherapy for Multiple Sclerosis in Switzerland—A Structured Commentary, Update 2022. Clinical and translational neuroscience, 7(1), p. 2. MDPI 10.3390/ctn7010002

Evangelopoulos, Maria Eleftheria; Hoepner, Robert; Mavragani, Clio (2023). Editorial: Demyelinating neurological syndromes: The role of autoimmunity. Frontiers in neurology, 14(1178980), p. 1178980. Frontiers Media S.A. 10.3389/fneur.2023.1178980

Salmen, Anke; Marti, Stefanie; Hoepner, Andreas G F; Chan, Andrew; Hoepner, Robert (2023). The impact of immunotherapies on COVID-19 case fatality rates during the US vaccination campaign: a multidisciplinary open data analysis using FDA Adverse Event Reporting System and Our World in Data. Frontiers in Pharmacology, 14(1186404), p. 1186404. Frontiers 10.3389/fphar.2023.1186404

Salmen, Anke; Hoepner, Robert; Fleischer, Vinzenz; Heldt, Milena; Gisevius, Barbara; Motte, Jeremias; Ruprecht, Klemens; Schneider, Ruth; Fisse, Anna Lena; Grüter, Thomas; Lukas, Carsten; Berthele, Achim; Giglhuber, Katrin; Flaskamp, Martina; Mühlau, Mark; Kirschke, Jan; Bittner, Stefan; Groppa, Sergiu; Lüssi, Felix; Bayas, Antonios; ... (2023). Factors associated with depressive mood at the onset of multiple sclerosis - an analysis of 781 patients of the German NationMS cohort. Therapeutic advances in neurological disorders, 16, p. 17562864231197309. Sage 10.1177/17562864231197309

Diem, Lara; Höfle, Oliver; Fregolente, Livia; Hoepner, Robert (2023). The Role of Neurorehabilitation in Post-COVID-19 Syndrome. Clinical and translational neuroscience, 7(2), p. 13. MDPI 10.3390/ctn7020013

Hammer, H; Kamm, CP; Salmen, A; Hoepner, R (2023). "Comparable Efficacy of SARS-CoV-2 mRNA Vaccines (BNT162b2 and mRNA-1273) in Fingolimod-Treated Patients with Multiple Sclerosis". Biomedical journal of scientific & technical research, 50(1) Biomedical Research Network+ 10.26717/BJSTR.2023.50.007885

Gonzalez-Machorro, Monica; Hecker, Pascal; Reichel, Uwe; Hammer, Helly N.; Hoepner, Robert; Pedrotti, Lisa; Zmutt, Alisha; Sagha, Hesam; Beek, Johan van; Eyben, Florian; Schuller, Dagmar M.; Schuller, Björn W.; Arnrich, Bert (2023). Towards Supporting an Early Diagnosis of Multiple Sclerosis using Vocal Features. In: INTERSPEECH 2023 (pp. 1518-1522). ISCA: ISCA 10.21437/Interspeech.2023-1759

2022

Diem, Lara; Schwarzwald, Anina; Friedli, Christoph; Hammer, Helly; Gomes-Fregolente, Livia; Warncke, Jan; Weber, Lea; Kamber, Nicole; Chan, Andrew; Bassetti, Claudio; Salmen, Anke; Hoepner, Robert (2022). Multidimensional phenotyping of the post-COVID-19 syndrome: A Swiss survey study. CNS neuroscience & therapeutics, 28(12), pp. 1953-1963. Wiley 10.1111/cns.13938

Diem, L; Evangelopoulos, M E; Karathanassis, D; Natsis, V; Kamber, N; Hammer, H; Friedli, C; Chan, A; Helbling, A; Penner, I K; Salmen, A; Walther, S; Stegmayer, K; Hoepner, R (2022). Hypogammaglobulinemia: A contributing factor to multiple sclerosis fatigue? Multiple Sclerosis and Related Disorders, 68, p. 104148. Elsevier 10.1016/j.msard.2022.104148

Chiavi, Deborah; Haag, Christina; Chan, Andrew; Kamm, Christian Philipp; Sieber, Chloé; Stanikić, Mina; Rodgers, Stephanie; Pot, Caroline; Kesselring, Jürg; Salmen, Anke; Rapold, Irene; Calabrese, Pasquale; Manjaly, Zina-Mary; Gobbi, Claudio; Zecca, Chiara; Walther, Sebastian; Stegmayer, Katharina; Hoepner, Robert; Puhan, Milo and von Wyl, Viktor (2022). Studying Real-World Experiences of Persons with Multiple Sclerosis during the first Covid-19 Lockdown: An Application of Natural Language Processing. JMIR medical informatics, 10(11), e37945. JMIR Publications 10.2196/37945

Hoepner, Robert; Rodgers, Stephanie; Stegmayer, Katharina; Steinemann, Nina; Haag, Christina; Calabrese, Pasquale; Manjaly, Zina-Mary; Salmen, Anke; Kesselring, Jürg; Zecca, Chiara; Gobbi, Claudio; Puhan, Milo A; Walther, Sebastian; von Wyl, Viktor (2022). Feelings of loneliness, COVID-19-specific-health anxiety and depressive symptoms during the first COVID-19 wave in Swiss persons with multiple sclerosis. Scientific reports, 12(1), p. 17829. Springer Nature 10.1038/s41598-022-22445-0

Hammer, H; Kamber, N; Pistor, M; Diem, L; Friedli, C; Chan, A; Hoepner, R; Salmen, A (2022). Ocrelizumab-related neutropenia: Effects of age, sex and bodyweight using the FDA Adverse Event Reporting System (FAERS). Multiple Sclerosis and Related Disorders, 65, p. 104015. Elsevier 10.1016/j.msard.2022.104015

Diem, Lara; Hoepner, Robert (2022). [Hypogammaglobulinemia and Multiple Sclerosis - An Overlooked Correlation?]. Therapeutische Umschau, 79(6), pp. 285-288. Hogrefe 10.1024/0040-5930/a001362

Guse, Kirsten; Hagemann, Nina; Thiele, Lisa; Remlinger, Jana; Salmen, Anke; Hoepner, Robert; Keller, Irene; Meyer, Patricia; Grandgirard, Denis; Leib, Stephen; Vassella, Erik; Locatelli, Giuseppe; Hermann, Dirk M; Chan, Andrew Hao-Kuang (2022). CNS Antigen-Specific Neuroinflammation Attenuates Ischemic Stroke With Involvement of Polarized Myeloid Cells. Neurology: neuroimmunology & neuroinflammation, 9(4) Wolters Kluwer Health 10.1212/NXI.0000000000001168

Hoepner, Robert; Kamm, Christian; Friedli, Christoph; Salmen, Anke; Chan, Andrew (2022). Is COVID-19 severity associated with reduction in T lymphocytes in anti-CD20-treated people with Multiple Sclerosis or Neuromyelitis Optica Spectrum Disorder? CNS neuroscience & therapeutics, 28(6), pp. 971-973. Wiley 10.1111/cns.13841

Schmid, Rahel Dominique; Remlinger, Jana; Abegg, Mathias; Hoepner, Robert; Hoffmann, Rainer; Lukas, Carsten; Saft, Carsten; Salmen, Anke (2022). No optical coherence tomography changes in premanifest Huntington's disease mutation carriers far from disease onset. Brain and Behavior, 12(6), e2592. Wiley 10.1002/brb3.2592

Hammer, Helly; Kamber, Nicole; Friedli, Christoph; Hoepner, Robert; Diem, Lara; Chan, Andrew; Salmen, Anke (2022). [Primary CNS Vasculitis - An Overview]. Therapeutische Umschau. Revue therapeutique, 79(5), pp. 247-253. Huber 10.1024/0040-5930/a001358

Schaub, Nora; Ammann, Nina; Conring, Frauke; Müller, Thomas; Federspiel, Andrea; Wiest, Roland; Hoepner, Robert; Stegmayer, Katharina; Walther, Sebastian (2022). Effect of Season of Birth on Hippocampus Volume in a Transdiagnostic Sample of Patients With Depression and Schizophrenia. Frontiers in human neuroscience, 16, p. 877461. Frontiers Research Foundation 10.3389/fnhum.2022.877461

Diem, Lara; Fregolente-Gomes, Livia; Warncke, Jan D; Hammer, Helly; Friedli, Christoph; Kamber, Nicole; Jung, Simon; Bigi, Sandra; Funke-Chambour, Manuela; Chan, Andrew; Bassetti, Claudio L; Salmen, Anke; Hoepner, Robert (2022). Fatigue in Post-COVID-19 Syndrome: Clinical Phenomenology, Comorbidities and Association With Initial Course of COVID-19. Journal of central nervous system disease, 14, p. 11795735221102727. Sage 10.1177/11795735221102727

Pistor, Maximilian; Hammer, Helly; Salmen, Anke; Hoepner, Robert; Friedli, Christoph (2022). Application of the "risk of ambulatory disability" (RoAD) score in a "real-world" single-center multiple sclerosis cohort. CNS neuroscience & therapeutics, 28(5), pp. 792-795. Wiley 10.1111/cns.13806

Sidler, Daniel; Born, Alexander; Schietzel, Simeon; Horn, Michael P; Aeberli, Daniel; Amsler, Jennifer; Möller, Burkhard; Njue, Linet M; Medri, Cesare; Angelillo-Scherrer, Anne; Borradori, Luca; Jafari, S Morteza Seyed; Radonjic-Hoesli, Susanne; Chan, Andrew; Hoepner, Robert; Bacher, Ulrike; Mani, Laila-Yasmin; Iype, Joseena Mariam; Suter-Riniker, Franziska; Staehelin, Cornelia; ... (2022). Trajectories of humoral and cellular immunity and responses to a third dose of mRNA vaccines against SARS-CoV-2 in patients with a history of anti-CD20 therapy. RMD open, 8(1) BMJ Publishing Group 10.1136/rmdopen-2021-002166

Remlinger, Jana; Madarasz, Adrian; Guse, Kirsten; Hoepner, Robert; Bagnoud, Maud; Meli, Ivo; Feil, Moritz; Abegg, Mathias; Linington, Christopher; Shock, Anthony; Boroojerdi, Babak; Kiessling, Peter; Smith, Bryan; Enzmann, Volker; Chan, Andrew; Salmen, Anke (2022). Antineonatal Fc Receptor Antibody Treatment Ameliorates MOG-IgG-Associated Experimental Autoimmune Encephalomyelitis. Neurology: neuroimmunology & neuroinflammation, 9(2) Wolters Kluwer Health 10.1212/NXI.0000000000001134

Hammer, H; Salmen, A; Kamber, N; Friedli, Chr; Diem, L; Hoepner, R; Chan, A (January 2022). Primäre ZNS-Vaskulitis. Rheuma Schweiz Fachzeitschrift, 2022(1), pp. 46-54.

Hammer, Helly; Hoepner, Robert; Friedli, Christoph; Leib, Stephen L; Suter-Riniker, Franziska; Diem, Lara; Kamber, Nicole; Chan, Andrew; Salmen, Anke; Kamm, Christian P (2022). Comparison of mRNA Vaccinations with BNT162b2 or mRNA-1273 in Anti-CD20-Treated Multiple Sclerosis Patients. Vaccines, 10(6), p. 922. MDPI 10.3390/vaccines10060922

Diem, Lara; Hammer, Helly; Hoepner, Robert; Pistor, Max; Remlinger, Jana; Salmen, Anke (2022). Sex and gender differences in autoimmune demyelinating CNS disorders: Multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD) and myelin-oligodendrocyte-glycoprotein antibody associated disorder (MOGAD). International Review of Neurobiology, 164, pp. 129-178. 10.1016/bs.irn.2022.06.011

Pistor, Maximilian; Hoepner, Robert; Hoepner, Andreas G F; Lin, Yanan; Jung, Simon; Bassetti, Claudio L; Chan, Andrew; Salmen, Anke (2022). Multiple Sclerosis immunotherapies and COVID-19 mortality: an analysis of the FDA Adverse Event Reporting System. Therapeutic advances in neurological disorders, 15(17562864221129383), p. 17562864221129383. Sage 10.1177/17562864221129383

Pistor, Maximilian; Salmen, Anke; Chan, Andrew; Hoepner, Robert (2022). COVID-19 in a Neuroimmunological Outpatient Cohort: The Bernese Experience. Clinical and translational neuroscience, 6(1), p. 6. MDPI 10.3390/ctn6010006

Hoepner, Robert; Salmen, Anke (2022). Waning Humoral Immune Response to SARS-CoV-2 Vaccination with Symptomatic Infection after Initiation of Anti-CD20 Treatment in a Patient with Multiple Sclerosis. Clinical and translational neuroscience, 6(1), p. 8. MDPI 10.3390/ctn6010008

Jost, Karin; Rodriguez, Belén; Söll, Nicole; Hoepner, Robert; Z'Graggen, Werner J (2022). Tolerability of COVID-19 mRNA vaccines in patients with postural tachycardia syndrome: a cross-sectional study. F1000Research, 11, p. 215. F1000 Research Ltd 10.12688/f1000research.109373.1

2021

Pistor, Maximilian; Hoepner, Andreas G F; Lin, Yanan; Jung, Simon; Bassetti, Claudio L; Chan, Andrew; Salmen, Anke; Hoepner, Robert (2021). Immunotherapies and COVID-19 mortality: a multidisciplinary open data analysis based on FDA's Adverse Event Reporting System. Annals of the rheumatic diseases, 80(12), pp. 1633-1635. BMJ Publishing Group 10.1136/annrheumdis-2021-220679

Moor, Matthias B.; Suter-Riniker, Franziska; Horn, Michael P.; Aeberli, Daniel; Amsler, Jennifer; Möller, Burkhard; Njue, Linet M.; Medri, Cesare; Angelillo-Scherrer, Anne; Borradori, Luca; Radonjic-Hoesli, Susanne; Seyed Jafari, S. Morteza; Chan, Andrew; Hoepner, Robert; Bacher, Vera Ulrike; Mani, Laila-Yasmin; Iype, Joseena Mariam; Hirzel, Cédric; Maurer, Britta and Sidler, Daniel (2021). Humoral and cellular responses to mRNA vaccines against SARS-CoV-2 in patients with a history of CD20 B-cell-depleting therapy (RituxiVac): an investigator-initiated, single-centre, open-label study. The Lancet. Rheumatology, 3(11), e789-e797. Elsevier 10.1016/S2665-9913(21)00251-4

Rodriguez, Belén; Hoepner, Robert; Salmen, Anke; Kamber, Nicole; Z'Graggen, Werner J. (2021). Immunomodulatory treatment in postural tachycardia syndrome: A case series. European journal of neurology, 28(5), pp. 1692-1697. Wiley 10.1111/ene.14711

Diem, Lara; Friedli, Christoph; Chan, Andrew; Salmen, Anke; Hoepner, Robert (2021). Vaccine Hesitancy in Patients With Multiple Sclerosis: Preparing for the SARS-CoV-2 Vaccination Challenge. Neurology: Neuroimmunology and Neuroinflammation, 8(3) Wolters Kluwer Health 10.1212/NXI.0000000000000991

Diem, L.; Hoepner, R.; Bagnoud, M.; Salmen, A.; Chan, A.; Friedli, C. (2021). Natalizumab induced blood eosinophilia: A retrospective pharmacovigilance cohort study and review of the literature. Journal of neuroimmunology, 353, p. 577505. Elsevier 10.1016/j.jneuroim.2021.577505

Veselaj, Krenar; Kamber, Nicole; Briner, Myriam; Friedli, Christoph; Diem, Lara; Guse, Kirsten; Miclea, Andrei; Wiest, Roland; Wagner, Franca; Grabe, Hilary; Abegg, Mathias; Horn, Michael P.; Bigi, Sandra; Chan, Andrew; Hoepner, Robert; Salmen, Anke (2021). Evaluation of diagnostic criteria and red flags of myelin oligodendrocyte glycoprotein encephalomyelitis in a clinical routine cohort. CNS neuroscience & therapeutics, 27(4), pp. 426-438. Wiley 10.1111/cns.13461

Kinner, M; Prehn, C; Schneider, R; Schroeder, C; Kolb, E; Gold, R; Hoepner, R; Chan, A (2021). Course of neuropsychological impairment during Natalizumab associated progressive multifocal leukoencephalopathy. European journal of neurology, 28(3), pp. 921-927. Wiley 10.1111/ene.14604

Wipke, Brian T; Hoepner, Robert; Strassburger-Krogias, Katrin; Thomas, Ankur M; Gianni, Davide; Szak, Suzanne; Brennan, Melanie S; Pistor, Maximilian; Gold, Ralf; Chan, Andrew; Scannevin, Robert H (2021). Different Fumaric Acid Esters Elicit Distinct Pharmacologic Responses. Neurology: Neuroimmunology and Neuroinflammation, 8(2) Wolters Kluwer Health 10.1212/NXI.0000000000000950

Friedli, Christoph; Diem, Lara; Hammer, Helly; Kamber, Nicole; Suter-Riniker, Franziska; Leib, Stephen; Chan, Andrew; Hirzel, Cédric; Hoepner, Robert; Salmen, Anke (2021). Negative SARS-CoV2-antibodies after positive COVID-19-PCR nasopharyngeal swab in patients treated with anti-CD20 therapies. Therapeutic advances in neurological disorders, 14, p. 17562864211016641. Sage 10.1177/17562864211016641

Funke-Chambour, Manuela; Feldmeyer, Laurence; Hoepner, Robert; Huynh-Do, Uyen; Maurer, Britta; Rexhaj, Emrush; Geiser, Thomas (2021). [The Long-COVID Syndrome - a New Clinical Picture after COVID-19 Infection]. Praxis, 110(7), pp. 377-382. Hogrefe 10.1024/1661-8157/a003678

Gili-Kovács, Judit; Hoepner, Robert; Salmen, Anke; Bagnoud, Maud; Gold, Ralf; Chan, Andrew; Briner, Myriam (2021). An algorithm using clinical data to predict the optimal individual glucocorticoid dosage to treat multiple sclerosis relapses. Therapeutic advances in neurological disorders, 14, p. 17562864211020074. Sage 10.1177/17562864211020074

Chaloulos-Iakovidis, Panagiotis; Wagner, Franca; Weber, Lea; Diem, Lara; Chan, Andrew; Salmen, Anke; Friedli, Christoph; Hoepner, Robert (2021). Predicting conversion to multiple sclerosis in patients with radiologically isolated syndrome: a retrospective study. Therapeutic advances in neurological disorders, 14, p. 17562864211030664. Sage 10.1177/17562864211030664

2020

Bagnoud, Maud; Briner, Myriam; Remlinger, Jana; Meli, Ivo; Schuetz, Sara; Pistor, Maximilian; Salmen, Anke; Chan, Andrew; Hoepner, Robert (2020). c-Jun N-Terminal Kinase as a Therapeutic Target in Experimental Autoimmune Encephalomyelitis. Cells, 9(10) MDPI 10.3390/cells9102154

Diem, Lara; Daponte, Ariadne; Findling, Oliver; Miclea, Andrei; Briner, Myriam; Salmen, Anke; Gold, Ralf; Kilidireas, Constantinos; Chan, Andrew; Evangelopoulos, Maria Elftheria; Hoepner, Robert (2020). Dimethyl fumarate vs fingolimod following different pretreatments: A retrospective study. Neurology: Neuroimmunology and Neuroinflammation, 7(2) Wolters Kluwer Health 10.1212/NXI.0000000000000660

Thiele née Schrewe, Lisa; Guse, Kirsten; Tietz, Silvia; Remlinger, Jana; Demir, Seray; Pedreiturria, Xiomara; Hoepner, Robert; Salmen, Anke; Pistor, Maximilian; Turner, Timothy; Engelhardt, Britta; Hermann, Dirk M; Lühder, Fred; Wiese, Stefan; Chan, Andrew (2020). Functional relevance of the multi-drug transporter abcg2 on teriflunomide therapy in an animal model of multiple sclerosis. Journal of neuroinflammation, 17(1), p. 9. BioMed Central 10.1186/s12974-019-1677-z

Miclea, Andrei; Bagnoud, Maud; Chan, Andrew; Hoepner, Robert (2020). A Brief Review of the Effects of Vitamin D on Multiple Sclerosis. Frontiers in immunology, 11(781), p. 781. Frontiers Research Foundation 10.3389/fimmu.2020.00781

Diem, Lara; Bürge, Maxine; Leichtle, Alexander; Hakim, Arsany; Chan, Andrew; Salmen, Anke; Evangelopoulos, Maria-Eleptheria; Hoepner, Robert (2020). Pathological cerebrospinal fluid protein concentration and albumin quotient at relapse predicts short-term disability progression in multiple sclerosis: a retrospective single center observational study. Therapeutic advances in neurological disorders, 13, p. 175628642097590. Sage 10.1177/1756286420975909

2019

Hoepner, Robert; Bagnoud, Maud; Pistor, Maximilian; Salmen, Anke; Briner, Myriam; Synn, Helen; Schrewe, Lisa; Guse, Kirsten; Ahmadi, Farhad; Demir, Seray; Laverick, Louis; Gresle, Melissa; Worley, Paul; Reichardt, Holger Michael; Butzkueven, Helmut; Gold, Ralf; Metz, Imke; Lühder, Fred; Chan, Andrew (2019). Vitamin D increases glucocorticoid efficacy via inhibition of mTORC1 in experimental models of multiple sclerosis. Acta neuropathologica, 138(3), pp. 443-456. Springer-Verlag 10.1007/s00401-019-02018-8

Hoepner, Robert; Weber, R.; Reimann, G.; Berger, K.; Kitzrow, M.; Fischer, S.; Weimar, C.; Eyding, J.; Krogias, C. (2019). Stroke admission outside daytime working hours delays mechanical thrombectomy and worsens short-term outcome. International journal of stroke, 14(5), pp. 517-521. Sage 10.1177/1747493018790079

Miclea, A.; Salmen, Anke; Zoehner, G.; Diem, Lara; Kamm, Christian P.; Chaloulos-Iakovidis, Panagiotis; Miclea, M.; Briner, Myriam Sandra; Kilidireas, K.; Stefanis, L.; Chan, Andrew; Evangelopoulos, Maria Eleptheria; Hoepner, Robert (2019). Age-dependent variation of female preponderance across different phenotypes of multiple sclerosis: A retrospective cross-sectional study. CNS neuroscience & therapeutics, 25(4), pp. 527-531. Blackwell Publishing 10.1111/cns.13083

Classen, G.; Classen, C.; Bernasconi, Corrado Angelo; Brandt, C.; Gold, R.; Chan, Andrew; Hoepner, Robert (2019). Quantitative electroencephalography supports diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy. Journal of neurovirology, 25(1), pp. 133-136. Springer 10.1007/s13365-018-0689-2

Miclea, Andrei; Salmen, Anke; Wiest, Roland; Zoehner, Greta; Wagner, Franca; Hoepner, Andreas; Schrewe, Lisa; Evangelopoulos, Maria-Eleptheria; Kamber, Nicole; Chan, Andrew Hao-Kuang; Hoepner, Robert (2019). Prediction of conversion to multiple sclerosis using the 2017 McDonald and 2016 MAGNIMS criteria in patients with clinically isolated syndrome: a retrospective single-centre study. Therapeutic advances in neurological disorders, 12, p. 1756286419835652. Sage 10.1177/1756286419835652

Briner, Myriam; Bagnoud, Maud; Miclea, Andrei; Friedli, Christoph; Diem, Lara; Chan, Andrew; Hoepner, Robert; Salmen, Anke (2019). Time course of lymphocyte repopulation after dimethyl fumarate-induced grade 3 lymphopenia: contribution of patient age. Therapeutic advances in neurological disorders, 12, p. 1756286419843450. Sage 10.1177/1756286419843450

Achtnichts, Lutz; Chan, Andrew; Czaplinski, Adam; Derfuss, Tobias; Du Pasquier, Renaud; Findling, Oliver; Gobbi, Claudio; Hoepner, Robert; Kamber, Nicole; Kamm, Christian P.; Kuhle, Jens; Lalive, Patrice; Lutterotti, Andreas; Martin, Roland; Mller, Stefanie; Papadopoulou, Athina; Pot, Caroline; Salmen, Anke; Schippling, Sven and Zecca, Chiara (2019). Besonderheiten der Immuntherapie der Multiplen Sklerose in der Schweiz. Swiss Medical Forum, 19(41-42), pp. 676-685. EMH Swiss Medical Publishers 10.4414/smf.2019.08356

Zoehner, Greta; Miclea, Andrei; Salmen, Anke; Kamber, Nicole; Diem, Lara; Friedli, Christoph; Bagnoud, Maud; Ahmadi, Farhad; Briner, Myriam; Sédille-Mostafaie, Nazanin; Kilidireas, Constantinos; Stefanis, Leonidas; Chan, Andrew; Hoepner, Robert; Evangelopoulos, Maria Eleftheria (2019). Reduced serum immunoglobulin G concentrations in multiple sclerosis: prevalence and association with disease-modifying therapy and disease course. Therapeutic advances in neurological disorders, 12, p. 1756286419878340. Sage 10.1177/1756286419878340

Skorupka, Nic; Miclea, Andrei; Jalowiec, Katarzyna Aleksandra; Bocksrucker, Christoph; Kamber, Nicole; Chan, Andrew; Mansouri Taleghani, Behrouz; Hoepner, Robert; Salmen, Anke (2019). Visual Outcomes of Plasma Exchange Treatment of Steroid-Refractory Optic Neuritis: A Retrospective Monocentric Analysis. Transfusion medicine and hemotherapy, 46(6), pp. 417-422. Karger 10.1159/000504027

Achtnichts, L; Chan, A; Czaplinski, A; Derfuss, T; Du Pasquier, R; Findling, O; Gobbi, C; Hoepner, R; Kamber, N; Kamm, C P; Kuhle, J; Lalive, P; Lutterotti, A; Martin, R; Müller, S; Papadopoulou, A; Pot, C; Salmen, A; Schippling, S and Zecca, C (2019). Specific aspects of immunotherapy for multiple sclerosis in Switzerland: A structured commentary. Clinical and translational neuroscience, 3(1), 2514183X1882207. Sage Publications 10.1177/2514183X18822073

2018

Miclea, A; Miclea, M; Pistor, M; Stegmayer, K.; Hoepner, Robert (2018). Intramuscular Testosterone Supplementation Ameliorates Depression in Hypogonadal Men: A Retrospective Study in an Outpatient Department. Pharmacopsychiatry, 51(6), pp. 257-262. Thieme 10.1055/s-0043-125214

Bern University (2018). mTOR Inhibitor-Corticoid Combination Therapy For Multiple Sclerosis (WO 2018/153984 A1)

Pistor, Maximilian; Schrewe, Lisa; Haupeltshofer, Steffen; Miclea, Andrei; Faissner, Simon; Chan, Andrew; Hoepner, Robert (2018). 1,25-OH vitamin D and AKT-inhibition increase glucocorticoid induced apoptosis in a model of T-cell acute lymphoblastic leukemia (ALL). Leukemia research reports, 9, pp. 38-41. Elsevier 10.1016/j.lrr.2018.01.003

Wagner, Franca; Grunder, Lorenz Nicolas; Hakim, Arsany; Kamber, Nicole; Horn, Michael; Müllner, Julia Nicole Maria; Hoepner, Robert; Wiest, Roland; Metz, Imke; Chan, Andrew; Salmen, Anke (2018). Rebound After Fingolimod and a Single Daclizumab Injection in a Patient Retrospectively Diagnosed With NMO Spectrum Disorder-MRI Apparent Diffusion Coefficient Maps in Differential Diagnosis of Demyelinating CNS Disorders. Frontiers in neurology, 9(782), p. 782. Frontiers Media S.A. 10.3389/fneur.2018.00782

Hoepner, Robert; Gold, Ralf (2018). Opportunistische Infektionen des zentralen Nervensystems. In: Fink, Gereon Rudolph; Gold, Ralf; Berlit, Peter (eds.) SOPs Neurologie (pp. 258-261). Thieme

Chan, Andrew; Kamber, Nicole; Hoepner, Robert; Salmen, Anke (2018). Fortschritte in der Therapie der Multiplen Sklerose. Therapeutische Umschau, 75(7), pp. 405-409. Huber 10.1024/0040-5930/a001016

2017

Miclea, Andrei; Miclea, Marius; Pistor, Maximilian; Hoepner, Andreas; Chan, Andrew; Hoepner, Robert (2017). Vitamin D supplementation differentially affects seasonal multiple sclerosis disease activity. Brain and Behavior, 7(8), e00761. Wiley 10.1002/brb3.761

Schneider, Ruth; Bellenberg, Barbara; Hoepner, Robert; Kolb, Eva-Maria; Ellrichmann, Gisa; Haghikia, Aiden; Gold, Ralf; Lukas, Carsten (2017). Metabolic profiles by 1H-magnetic resonance spectroscopy in natalizumab-associated post-PML lesions of multiple sclerosis patients who survived progressive multifocal leukoencephalopathy (PML). PLoS ONE, 12(4), e0176415. Public Library of Science 10.1371/journal.pone.0176415

Schneider, Ruth; Bellenberg, Barbara; Hoepner, Robert; Ellrichmann, Gisa; Gold, Ralf; Lukas, Carsten (2017). Insight into Metabolic 1H-MRS Changes in Natalizumab Induced Progressive Multifocal Leukoencephalopathy Brain Lesions. Frontiers in neurology, 8(454), p. 454. Frontiers Media S.A. 10.3389/fneur.2017.00454

Provide Feedback